Prognozy (mln) dla Pfizer Inc.
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
63,083.18 |
62,436.17 |
62,230.07 |
61,017.70 |
57,820.40 |
55,066.12 |
Przychód Δ r/r |
0.00% |
-1.03% |
-0.33% |
-1.95% |
-5.24% |
-4.76% |
Przychód (min) |
62,674.97 |
62,177.84 |
60,801.32 |
60,972.33 |
56,291.61 |
53,610.15 |
Przychód (max) |
63,640.73 |
62,615.01 |
63,331.40 |
61,063.06 |
58,963.31 |
56,154.59 |
EBITDA (średnia) |
19,559.06 |
19,358.45 |
19,294.55 |
18,918.65 |
17,927.33 |
17,073.36 |
EBIT (średnia) |
13,960.06 |
13,816.88 |
13,771.27 |
13,502.98 |
12,795.43 |
12,185.92 |
EBIT % |
22.13% |
22.13% |
22.13% |
22.13% |
22.13% |
22.13% |
Zysk netto (średni) |
7,867.00 |
17,106.21 |
17,300.44 |
13,697.22 |
15,773.04 |
14,082.99 |
Zysk netto % |
12.47% |
27.40% |
27.80% |
22.45% |
27.28% |
25.57% |
EPS (średnia) |
2.93 |
3.00 |
3.09 |
3.09 |
2.77 |
2.47 |
Liczba analityków (Przychody) |
16 |
13 |
17 |
20 |
10 |
11 |
Liczba analityków (EPS) |
14 |
16 |
13 |
9 |
4 |
3 |
symbol |
PFE |
PFE |
PFE |
PFE |
PFE |
PFE |